MX2007004244A - Metodo para el aislamiento de haptoglobina. - Google Patents

Metodo para el aislamiento de haptoglobina.

Info

Publication number
MX2007004244A
MX2007004244A MX2007004244A MX2007004244A MX2007004244A MX 2007004244 A MX2007004244 A MX 2007004244A MX 2007004244 A MX2007004244 A MX 2007004244A MX 2007004244 A MX2007004244 A MX 2007004244A MX 2007004244 A MX2007004244 A MX 2007004244A
Authority
MX
Mexico
Prior art keywords
human
fraction
anion exchange
substrate
cohn
Prior art date
Application number
MX2007004244A
Other languages
English (en)
Spanish (es)
Inventor
John Dalton
Adrian Podmore
Peter Kumpalume
Original Assignee
Nhs Blood & Transplant
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nhs Blood & Transplant filed Critical Nhs Blood & Transplant
Publication of MX2007004244A publication Critical patent/MX2007004244A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1722—Plasma globulins, lactoglobulins
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4717—Plasma globulins, lactoglobulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Semiconductor Lasers (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MX2007004244A 2004-10-19 2005-10-19 Metodo para el aislamiento de haptoglobina. MX2007004244A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0423196.5A GB0423196D0 (en) 2004-10-19 2004-10-19 Method
PCT/GB2005/004037 WO2006043062A1 (en) 2004-10-19 2005-10-19 Method for the isolation of haptoglobin

Publications (1)

Publication Number Publication Date
MX2007004244A true MX2007004244A (es) 2007-09-07

Family

ID=33484812

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007004244A MX2007004244A (es) 2004-10-19 2005-10-19 Metodo para el aislamiento de haptoglobina.

Country Status (13)

Country Link
US (1) US9145448B2 (cg-RX-API-DMAC7.html)
EP (1) EP1802654B1 (cg-RX-API-DMAC7.html)
JP (1) JP4950053B2 (cg-RX-API-DMAC7.html)
AT (1) ATE539085T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005297061B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0516933B8 (cg-RX-API-DMAC7.html)
CA (1) CA2584407C (cg-RX-API-DMAC7.html)
ES (1) ES2379157T3 (cg-RX-API-DMAC7.html)
GB (1) GB0423196D0 (cg-RX-API-DMAC7.html)
IL (1) IL182340A (cg-RX-API-DMAC7.html)
MX (1) MX2007004244A (cg-RX-API-DMAC7.html)
PL (1) PL1802654T3 (cg-RX-API-DMAC7.html)
WO (1) WO2006043062A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0423196D0 (en) 2004-10-19 2004-11-24 Nat Blood Authority Method
US9534029B2 (en) 2012-10-03 2017-01-03 Csl Behring Ag Method of purifying proteins
CA2886726C (en) * 2012-10-03 2021-11-23 Csl Behring Llc A method of purifying proteins
EP3917943A4 (en) * 2019-02-01 2022-12-07 Ohio State Innovation Foundation PROTEINS PURIFICATION PROCEDURES
WO2020236952A1 (en) * 2019-05-20 2020-11-26 Ohio State Innovation Foundation Apohemoglobin-haptoglobin complexes and methods of using thereof
WO2022169206A1 (ko) * 2021-02-04 2022-08-11 ㈜Gc녹십자 헤모펙신 및 합토글로빈의 정제 방법
CN115531921B (zh) * 2022-08-26 2024-07-16 大连依利特分析仪器有限公司 一种制备型液相色谱馏分收集装置及方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5337406B2 (cg-RX-API-DMAC7.html) * 1973-11-15 1978-10-09
US4061735A (en) * 1973-11-15 1977-12-06 The Green Cross Corporation Haptoglobin in aqueous solution and process for preparing the same
GB1426039A (en) 1973-11-15 1976-02-25 Green Cross Corp Haptoglobin in aqueous solution and process for tits preparation
US4137307A (en) * 1973-11-15 1979-01-30 The Green Cross Corporation Process for preparing haptoglobin aqueous solution using strong anion exchanger
JPS52128205A (en) * 1976-04-16 1977-10-27 Green Cross Corp:The Prophylactic and therapeutic drugs for cerebro-vascular contraction
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US5094960A (en) * 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
JP3554796B2 (ja) 1988-10-31 2004-08-18 三菱ウェルファーマ株式会社 アルブミン製剤及びその製造方法
JP3825061B2 (ja) * 1994-09-28 2006-09-20 三菱ウェルファーマ株式会社 ハプトグロビンの製造方法
DE19960500A1 (de) 1999-12-15 2001-07-12 Giesing Michael Antikörper und Verfahren zu ihrer Herstellung, deren Verwendung sowie Immunisierungscocktails, Immunoassay-Sets und Peptide
DE60140069D1 (de) * 2000-10-16 2009-11-12 Cytoguide Aps Funktion eines haptoglobin-hämoglobin-rezeptors und anwendungszwecke dafür
US20030113830A1 (en) 2001-07-11 2003-06-19 Rappaport Family Institute For Research In The Medical Sciences Novel antioxidant, nucleic acid constructs encoding same, pharmaceutical compositions containing same and use of same for reducing oxidative-stress
JP2004244348A (ja) * 2003-02-13 2004-09-02 Nihon Pharmaceutical Co Ltd パプトグロビンの精製法
GB0423196D0 (en) 2004-10-19 2004-11-24 Nat Blood Authority Method
WO2006107708A1 (en) 2005-04-04 2006-10-12 Alexion Pharmaceuticals, Inc. Treatment of disease caused by excess free hemoglobin

Also Published As

Publication number Publication date
EP1802654A1 (en) 2007-07-04
BRPI0516933B1 (pt) 2021-02-09
ES2379157T3 (es) 2012-04-23
PL1802654T3 (pl) 2012-05-31
GB0423196D0 (en) 2004-11-24
ATE539085T1 (de) 2012-01-15
US9145448B2 (en) 2015-09-29
WO2006043062A1 (en) 2006-04-27
CA2584407A1 (en) 2006-04-27
BRPI0516933B8 (pt) 2021-05-25
AU2005297061A1 (en) 2006-04-27
JP2008517046A (ja) 2008-05-22
BRPI0516933A (pt) 2008-09-23
EP1802654B1 (en) 2011-12-28
US20090281282A1 (en) 2009-11-12
JP4950053B2 (ja) 2012-06-13
CA2584407C (en) 2015-02-03
AU2005297061B2 (en) 2011-09-01
IL182340A0 (en) 2007-07-24
IL182340A (en) 2012-06-28

Similar Documents

Publication Publication Date Title
JP4445202B2 (ja) 治療的使用のためのヒト免疫グロブリン濃縮物の調製方法
USRE44558E1 (en) Chromatographic method for high yield purification and viral inactivation of antibodies
KR100501263B1 (ko) 정맥 주사용 면역글로불린의 제조 방법 및 그 외의 면역글로불린 제품
JP6876655B2 (ja) タンパク質の精製方法
JP2002517516A (ja) 静脈投与用免疫グロブリン及び他の免疫グロブリン生成物の製造法
CN103153333B (zh) 补体因子h的纯化方法
JPH0381290A (ja) 精製されたアルブミン溶液の製造方法
CN103319592B (zh) 通过热处理获得IgG组合物的方法
AU2005297061B2 (en) Method for the isolation of haptoglobin
TWI593702B (zh) 純化由細胞培養而來的alpha蛋白酶抑制劑
AU2006321447B2 (en) Method for the purification of alpha-1-antitrypsin
JP2005508892A (ja) Gc−グロブリンの大規模生産のための精製方法、これにより得られる物質およびそれらの医薬用途
JP2026502812A (ja) 混合モードクロマトグラフィーを使用するヘモペキシンの精製方法
HK40050028A (en) A method of purifying proteins
NZ731196B2 (en) A novel purification process for isolation and commercial production of recombinant tnk-tpa (tenecteplase)
WO2000043412A1 (en) Compositions containing highly purified heparin cofactor ii and method for separating the same
HUE025551T2 (en) A method of producing virus-inactivated FV concentrate starting from human plasma, which can be increased to industrial sizes

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights